Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | info@bm.net

Newsroom Search

featured news

May 14, 2014 Healthcare Fraud

U.S. Government Intervenes in Power Wheelchair False Claims Case Against Orbit Medical Inc.

Power wheelchair claims are one of the most costly medical device codes submitted to Medicare and Medicaid each year. So much so, that the Office of Inspector General conducted a study in 2001 to determine whether these chairs are actually “medically necessary” in most cases and, if so, whether a […]
May 9, 2014 Healthcare Fraud

Tennessee Substance Abuse Facility New Life Lodge Settles Allegations of Medicaid Fraud

In a recent settlement out of Tennessee, California-based CRC Health Group, Inc. has agreed to pay $9.25 million to settle allegations of Medicaid fraud involving one of its addiction treatment centers located in the city of Burns. The settlement is the result of a joint investigation by the Tennessee Attorney […]
May 7, 2014 Healthcare Fraud

Doctor Settles Allegations of Performing Unnecessary Nasal Surgery on Pediatric Medicaid Patients

In yet another healthcare fraud case, an Oklahoma-based hospital, its parent company Health Management Associates, and Dr. Daniel Castro have agreed to settle a whistleblower lawsuit filed under the federal False Claims Act and its Oklahoma counterpart. According to the allegations found in the complaint, the medical professionals involved were […]
May 6, 2014 Healthcare Fraud

Hope Center Institute Submits False Claims to Federal Government, Settles for $2.9 Million

The Kansas-based cancer center known as Hope Cancer Institute and one of its physicians recently settled with the U.S. government over allegations of fraudulent billing practices. In the healthcare industry alone, the False Claims Act has been pivotal in recovering billions of dollars on behalf of American taxpayers. In fact, […]
April 25, 2014 Healthcare Fraud

Pfizer Unsuccessful in Avoiding Off-Label Marketing False Claims Act Case

In a recent False Claims Act case involving the mental health drug Geodon, Pfizer reportedly lost its bid to have the case dismissed after unsuccessfully arguing, among other claims, that relators failed the “first-to-file” and “public disclosure” requirements contained within the language of the FCA. Specifically, the FCA precludes whistleblowers […]
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

$50B+
in Settlements & Verdicts
50+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated

On the Cutting Edge of the Profession

Legal Intelligencer